Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.6
Journals
Biology
Special Issues
Animal Disease Models and Patient-iPS Cell Derived In Vitro Disease...
share announcement

Animal Disease Models and Patient-iPS Cell Derived In Vitro Disease Models for Cardiovascular Biology—How Close to Disease?

A special issue of Biology (ISSN 2079-7737).

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5398

Special Issue Editors

Dr. Nanako Kawaguchi

E-Mail Website
Guest Editor
Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women’s Medical University, Tokyo 162-8666, Japan
Interests: stem cells; chemokines; macrophagse; CXCR4; SDF-1; iPS cells
Special Issues, Collections and Topics in MDPI journals
Dr. Toshio Nakanishi

E-Mail Website
Guest Editor
Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women’s Medical University, Tokyo 162-8666, Japan
Interests: stem cell; regeneration
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Currently, murines, rodents, canines, and pigs are used as disease models in cardiovascular research. Larger animals that are more closely related to humans make better-suited disease models. However, they can have restricted or limited use, as they are difficult to handle and maintain. Moreover, experimental animals are regulated by animal welfare policies. Different species have different internal disease onset mechanisms. Nonetheless, preclinical studies use animals to check the safety and efficacy of human drugs because no other complementary method exists. Hence, we need to evaluate the similarities and differences in the disease mechanisms between humans and experimental animals. Humanized or chimerically humanized animal models can be used to more closely imitate human systems, especially when stem cells are involved. Humanized animal models use immuno-deficient mice and transplant human disease cells, such as cancer cells. In cardiovascular disease research, bone marrow stem cells (BMSCs) have been studied to treat myocardial infarction (MI). For this purpose, human BMSCs were injected into a humanized chimeric mouse with irradiated bone marrow.

Human cardiac cells, such as cardiomyocytes have been generated from patient-derived induced pluripotent stem cells (iPSCs) since iPSCs were first discovered. The patient-derived iPSCs and the cardiac cells were genetically equal to those that derived from the patient. However, variations in human iPSCs (hiPSCs) and hiPSCs-derived cardiomyocytes (hiPSCs-CMs) make it difficult to analyze disease-specific differences. Researchers have tried to develop 3D-culture systems that mimic in vivo conditions using various iPSC-derived cardiac cells to overcome this issue.

In this Special Issue, we would like to explore the possibility of animal disease models and iPSC-derived in vitro disease models.

Dr. Nanako Kawaguchi
Dr. Toshio Nakanishi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • animal disease model
  • iPS cells
  • transgenic
  • mutation
  • stem cells
  • in vitro
  • in vivo
  • patient-derived iPSCs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

15 pages, 19584 KiB  
Article
Ability of the Right Ventricle to Serve as a Systemic Ventricle in Response to the Volume Overload at the Neonatal Stage
by Chunxia Zhou, Debao Li, Qing Cui, Qi Sun, Yuqing Hu, Yingying Xiao, Chuan Jiang, Lisheng Qiu, Haibo Zhang, Lincai Ye and Yanjun Sun
Biology 2022, 11(12), 1831; https://doi.org/10.3390/biology11121831 - 15 Dec 2022
Cited by 2 | Viewed by 1706
Abstract
Background: In children with hypoplastic left heart syndrome (HLHS), volume overload (VO) is inevitable, and the right ventricle (RV) pumps blood into the systemic circulation. Understanding the molecular differences and their different responses to VO between the RV and left ventricle (LV) at [...] Read more.
Background: In children with hypoplastic left heart syndrome (HLHS), volume overload (VO) is inevitable, and the right ventricle (RV) pumps blood into the systemic circulation. Understanding the molecular differences and their different responses to VO between the RV and left ventricle (LV) at the neonatal and highly plastic stages may improve the long-term management of children with HLHS. Methods and Results: A neonatal rat ventricular VO model was established by the creation of a fistula between the inferior vena cava and the abdominal aorta on postnatal day 1 (P1) and confirmed by echocardiographic and histopathological analyses. Transcriptomic analysis demonstrated that some of the major differences between a normal neonatal RV and LV were associated with the thyroid hormone and insulin signaling pathways. Under the influence of VO, the levels of insulin receptors and thyroid hormone receptors were significantly increased in the LV but decreased in the RV. The transcriptomic analysis also demonstrated that under the influence of VO, the top two common enriched pathways between the RV and LV were the insulin and thyroid hormone signaling pathways, whereas the RV-specific enriched pathways were primarily associated with lipid metabolism and arrhythmogenic right ventricular cardiomyopathy (ARVC); further, the LV-specific enriched pathways were primarily associated with nucleic acid metabolism and microRNAs in cancer. Conclusions: Insulin and thyroid hormones may play critical roles in the differences between a neonatal RV and LV as well as their common responses to VO. Regarding the isolated responses to VO, the RV favors an ARVC change and the LV favors a reduction in microRNAs in cancer. The current study suggests that insulin, thyroid hormone, and cancer-associated microRNAs are potential therapeutic targets that should be explored by basic science studies to improve the function of the RV to match that of the LV. Full article
(This article belongs to the Special Issue Animal Disease Models and Patient-iPS Cell Derived In Vitro Disease Models for Cardiovascular Biology—How Close to Disease?)
►▼ Show Figures

Graphical abstract

Review

Jump to: Research

14 pages, 998 KiB  
Review
Animal Disease Models and Patient-iPS-Cell-Derived In Vitro Disease Models for Cardiovascular Biology—How Close to Disease?
by Nanako Kawaguchi and Toshio Nakanishi
Biology 2023, 12(3), 468; https://doi.org/10.3390/biology12030468 - 20 Mar 2023
Cited by 3 | Viewed by 3060
Abstract
Currently, zebrafish, rodents, canines, and pigs are the primary disease models used in cardiovascular research. In general, larger animals have more physiological similarities to humans, making better disease models. However, they can have restricted or limited use because they are difficult to handle [...] Read more.
Currently, zebrafish, rodents, canines, and pigs are the primary disease models used in cardiovascular research. In general, larger animals have more physiological similarities to humans, making better disease models. However, they can have restricted or limited use because they are difficult to handle and maintain. Moreover, animal welfare laws regulate the use of experimental animals. Different species have different mechanisms of disease onset. Organs in each animal species have different characteristics depending on their evolutionary history and living environment. For example, mice have higher heart rates than humans. Nonetheless, preclinical studies have used animals to evaluate the safety and efficacy of human drugs because no other complementary method exists. Hence, we need to evaluate the similarities and differences in disease mechanisms between humans and experimental animals. The translation of animal data to humans contributes to eliminating the gap between these two. In vitro disease models have been used as another alternative for human disease models since the discovery of induced pluripotent stem cells (iPSCs). Human cardiomyocytes have been generated from patient-derived iPSCs, which are genetically identical to the derived patients. Researchers have attempted to develop in vivo mimicking 3D culture systems. In this review, we explore the possible uses of animal disease models, iPSC-derived in vitro disease models, humanized animals, and the recent challenges of machine learning. The combination of these methods will make disease models more similar to human disease. Full article
(This article belongs to the Special Issue Animal Disease Models and Patient-iPS Cell Derived In Vitro Disease Models for Cardiovascular Biology—How Close to Disease?)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop